Toxicity and tissue distribution of magnetic nanoparticles in mice.
The development of technology enables the reduction of material size in science. The use of particle reduction in size from micro to nanoscale not only provides benefits to diverse scientific fields but also poses potential risks to humans and the environment. For the successful application of nanomaterials in bioscience, it is essential to understand the biological fate and potential toxicity of nanoparticles. The aim of this study was to evaluate the biological distribution as well as the potential toxicity of magnetic nanoparticles to enable their diverse applications in life science, such as drug development, protein detection, and gene delivery. We recently synthesized biocompatible silica-overcoated magnetic nanoparticles containing rhodamine B isothiocyanate (RITC) within a silica shell of controllable thickness [MNPs@SiO2(RITC)]. In this study, the MNPs@SiO2(RITC) with 50-nm thickness were used as a model nanomaterial. After intraperitoneal administration of MNPs@SiO2(RITC) for 4 weeks into mice, the nanoparticles were detected in the brain, indicating that such nanosized materials can penetrate blood-brain barrier (BBB) without disturbing its function or producing apparent toxicity. After a 4-week observation, MNPs@SiO2(RITC) was still present in various organs without causing apparent toxicity. Taken together, our results demonstrated that magnetic nanoparticles of 50-nm size did not cause apparent toxicity under the experimental conditions of this study.
Kim
Jun Sung
JS
Laboratory of Toxicology, College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National University, Seoul 151-742, Korea.
Yoon
Tae-Jong
TJ
Yu
Kyeong Nam
KN
Kim
Byung Gul
BG
Park
Sung Jin
SJ
Kim
Hyun Woo
HW
Lee
Kee Ho
KH
Park
Seung Bum
SB
Lee
Jin-Kyu
JK
Cho
Myung Haing
MH
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects* / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D020099:Coated Materials, Biocompatible; D016503:Drug Delivery Systems; D005260:Female; D007274:Injections, Intraperitoneal; D008280:Magnetics; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D049329:Nanostructures / Q000633:toxicity*; D012235:Rhodamines / Q000737:chemistry / Q000493:pharmacokinetics / Q000633:toxicity*; D012822:Silicon Dioxide / Q000737:chemistry / Q000493:pharmacokinetics / Q000633:toxicity*; D014018:Tissue Distribution
D020099:Coated Materials, Biocompatible; D012235:Rhodamines; D012822:Silicon Dioxide; C027755:rhodamine isothiocyanate